Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors

International Journal of Radiation Biology

Volumn 79, Issue 2, 2003, Pages 129-136

  Hayashi, T ^a   Kusunoki, Y ^a   Hakoda, M ^a   Morishita, Y ^a   Kubo, Y ^a   Maki, M ^a   Kasagi, F ^a   Kodama, K ^a   MacPhee, D G ^a   Kyoizumi, S ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ATOMIC BOMB; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE;

MURINAE;

EID: 0037317216     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/0955300021000038662     Document Type: Article

References (26)

1. DANESH, J., WHINCUP, P., WALKER, M., LENNON, L., THOMSON, A., APPLEBY, P., GALLIMORE, J. R. and PEPYS, M. B., 2000, Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal, 321, 199-204.
2. GIRINSKY, T. A., PALLARDY, M., COMOY, E., BENASSI, T., ROGER, R., GANEM, G., COSSET, J. M., SOCIE, G. and MAGDELENAT, H., 1994, Peripheral blood corticotropin-releasing factor, adrenocorticotropic hormone and cytokine (interleukin beta, interleukin 6, rumor necrosis factor alpha) levels after high- and low-dose total-body irradiation in humans. Radiation Research, 139, 360-363.
3. HAVEMAN, J., GEERDINK, A. G. and RODERMOND, H. M., 1998, TNF, IL-1 and IL-6 in circulating blood after total-body and localized irradiation in rats. Oncology Reports, 5, 679-683.
4. HEINRICH, P. C., CASTELL, J. V. and ANDUS, T., 1990, Interleukin-6 and the acute phase response. Biochemical Journal, 265, 621-636.
5. HERODIN, F., MESTRIES, J. C., JANODET, D., MARTIN, S., MATHIEU, J., GASCON, M. P., PERNIN, M. O. and YTHIER, A., 1992, Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood, 80, 688-695.
6. KISHIMOTO, T., 1989, The biology of interleukin-6. Blood, 74, 1-10.
7. KODAMA, K., MABUCHI, K. and SHIGEMATSU, I., 1996, A long-term cohort study of the atomic-bomb survivors. Journal of Epidemiology, 6, S95-105.
8. KOENIG, W., SUND, M., FROHLICH, M., FISCHER, H. G., LOWEL, H., DORING, A., HUTCHINSON, W. L. and PEPYS, M. B., 1999, C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation, 99, 237-242.
9. KUSUNOKI, Y., KYOIZUMI, S., HIRAI, Y., SUZUKI, T., NAKASHIMA, E., KODAMA, K. and SEYAMA, T., 1998, Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiation Research, 150, 227-236.
10. KUSUNOKI, Y., KYOIZUMI, S., YAMAOKA, M., KASAGI, F., KODAMA, K. and SEYAMA, T., 1999, Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction. Radiation Research, 152, 539-543; erratum 154, 119.
11. MENDALL, M. A., STRACHAN, D. P., BUTLAND, B. K., BALLAM, L., MORRIS, J., SWEETNAM, P. M. and ELWOOD, P. C., 2000, C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. European Heart Journal, 21, 1584-1590.
12. NERIISHI, K., AKIBA, S., AMANO, T., OGINO, T. and KODAMA, K., 1995, Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiation Research, 144, 215-221.
13. NERIISHI, K., NAKASHIMA, E. and DELONGCHAMP, R. R., 2001, Persistent subclinical inflammation among A-bomb survivors. International Journal of Radiation Biology, 77, 475-482.
14. PIERCE, D. A., SHIMIZU, Y., PRESTON, D. L., VAETH, M. and MABUCHI, K., 1996, Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiation Research, 146, 1-27.
15. PIERCE, D. A., VAETH, M. and PRESTON, D. L., 1991, Analysis of time and age patterns in cancer risk for A-bomb survivors. Radiation Research, 126, 171-186.
16. RIDKER, P. M., 2001, High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 103, 1813-1818.
17. RIDKER, P. M., CUSHMAN, M., STAMPFER, M. J., TRACY, R. P. and HENNEKENS, C. H., 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973-979.
18. RIDKER, P. M., RIFAI, N., STAMPFER, M. J. and HENNEKENS, C. H., 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101, 1767-1772.
19. RIDKER, P. M., STAMPFER, M. J. and RIFAI, N., 2001, Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of the American Medical Association, 285, 2481-2485.
20. ROESCH, W. C., 1987, US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki (Hiroshima: Radiation Effects Research Foundation).
21. ROSS, R., 1999, Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 340, 115-126.
22. SAWADA, H., KODAMA, K., SHIMIZU, Y. and KATO, H., 1986, Adult health study report 6. Results of six examination cycles, 1968-1980, Hiroshima and Nagasaki. Radiation Effects Research Foundation Technical Reports, 3-86.
23. SHIGEMATSU, I., 1998, Greetings: 50 years of Atomic Bomb Casualty Commission - Radiation Effects Research Foundation studies. Proceedings of the National Academy of Sciences of the United States of America, 95, 5424-5425.
24. SHIMIZU, Y., KATO, H. and SCHULL, W. J., 1991, Risk of cancer among atomic bomb survivors. Journal of Radiation Research (Tokyo), 32 (Suppl. 2), 54-63.
25. SHIMIZU, Y., PIERCE, D. A., PRESTON, D. L. and MABUCHI, K., 1999, Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiation Research, 152, 374-389.
26. WONG, F. L., YAMADA, M., SASAKI, H., KODAMA, K., AKIBA, S., SHIMAOKA, K. and HOSODA, Y., 1993, Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiation Research, 135, 418-430.